Sesión 2015 02 19 (Caso SALUPHARMA, S.a. -Objetivos)
-
Upload
miriam-natareno -
Category
Documents
-
view
244 -
download
0
description
Transcript of Sesión 2015 02 19 (Caso SALUPHARMA, S.a. -Objetivos)
-
VENTAS
PRODUCTO
0
VENTAS
PRODUCTO
1
VENTAS
INDUSTRIA
0
VENTAS
INDUSTRIA
1
MARKET
SHARE 0
MARKET
SHARE 1POSICIN 0 POSICIN 1
%
PRODUCTO
%
INDUSTRIARMSh EVOLUCIN
VENTAS
PRODUCTO
2
%
PRODUCTO
2
MARKET
SHARE 2
HONGUIFN 30,000 15,000 160,000 122,000 18.75 12.30 1 7 -50.00 -23.75 0.56 65.57
DOLFN 2,000 3,000 11,100 14,400 18.02 20.83 2 2 50.00 29.73 0.46 115.62
DESGAFN 1,000 1,850 3,900 5,100 25.64 36.27 1 1 85.00 30.77 2.64 141.48
ACIFN 200 300 810 820 24.69 36.59 2 1 50.00 1.23 1.50 148.15
RESFRIAFN 100 150 170 440 58.82 34.09 1 1 50.00 158.82 1.88 57.92
REDFN 100 75 1,425 1,875 7.02 4.00 5 7 -25.00 31.58 0.13 57.00
SALUPHARMA 33,400 20,375 177,405 144,635 -39.00 -18.47
GUATEMALA UNITED STATES OF AMERICA
http://sites.google.com/site/holoscorp www.andronikos.org
(502) 5204-3908 (1+951) 479-7172
SALUPHARMA
-
GUATEMALA UNITED STATES OF AMERICA
http://sites.google.com/site/holoscorp www.andronikos.org
(502) 5204-3908 (1+951) 479-7172
REDFN
DESGAFN
DOLFN
HONGUIFN
PRODUCTO ESTRATEGIA OBJETIVO ESPECFICOOBJETIVO
GENERAL
ACIFN
RESFRIAFN